Wearable Injectors Market Size

Wearable Injectors Market size was valued at USD 8.63 billion in 2023 and is set to cross USD 31.98 billion by 2036, expanding at more than 10.6% CAGR during the forecast period i.e., between 2024-2036. In the year 2024, the industry size of wearable injectors is evaluated at USD 9.36 billion. The growing prevalence of chronic medical conditions and increasing geriatric population, along with the technological developments in drug delivery injectors globally, are expected to fuel the progress of this market in the near future. According to the data collected from Organization for Economic Co-operation & Development (OECD), in 2019, about 33% of the total population of OECD countries aged 15 years and more had two or more chronic conditions, and the number increased to 58% in persons with age more than 65 years. Moreover, the ability of wearable injectors to administer new formulations with higher volume and viscosity can significantly improve the patient experience, which in turn is expected to boost market growth in the coming years. The growth of the market can also be attributed to factors such as the continuous expansion in research for the development of biologics and favorable reimbursement policies for wearable injectors in prominent economic regions.